BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21040736)

  • 1. Effects of epidermal turnover on the dynamics of percutaneous drug absorption.
    Simon L; Kim KS; Kanneganti K
    Math Biosci; 2011 Jan; 229(1):16-21. PubMed ID: 21040736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics and control of percutaneous drug absorption in the presence of epidermal turnover.
    Simon L; Goyal A
    J Pharm Sci; 2009 Jan; 98(1):187-204. PubMed ID: 18481307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interfacial kinetics effects on transdermal drug delivery: a computer modeling.
    Xing MM; Pan N; Zhong W; Hui X; Maibach HI
    Skin Res Technol; 2008 May; 14(2):165-72. PubMed ID: 18412558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the method of homogenization to calculate the effective diffusivity of the stratum corneum with permeable corneocytes.
    Rim JE; Pinsky PM; van Osdol WW
    J Biomech; 2008; 41(4):788-96. PubMed ID: 18093598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does epidermal turnover reduce percutaneous penetration?
    Reddy MB; Guy RH; Bunge AL
    Pharm Res; 2000 Nov; 17(11):1414-9. PubMed ID: 11205736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defense against dermal exposures is only skin deep: significantly increased penetration through slightly damaged skin.
    Nielsen JB; Nielsen F; Sørensen JA
    Arch Dermatol Res; 2007 Nov; 299(9):423-31. PubMed ID: 17882442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling of diffusion with partitioning in stratum corneum using a finite element model.
    Barbero AM; Frasch HF
    Ann Biomed Eng; 2005 Sep; 33(9):1281-92. PubMed ID: 16133933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical delivery of lipophilic drugs from o/w Pickering emulsions.
    Frelichowska J; Bolzinger MA; Pelletier J; Valour JP; Chevalier Y
    Int J Pharm; 2009 Apr; 371(1-2):56-63. PubMed ID: 19135516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-dimensional transport analysis of transdermal drug absorption with a non-perfect sink boundary condition at the skin-capillary interface.
    Simon L; Ospina J
    Math Biosci; 2013 Jul; 244(1):58-67. PubMed ID: 23624255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stratum corneum is an effective barrier to TiO2 and ZnO nanoparticle percutaneous absorption.
    Filipe P; Silva JN; Silva R; Cirne de Castro JL; Marques Gomes M; Alves LC; Santus R; Pinheiro T
    Skin Pharmacol Physiol; 2009; 22(5):266-75. PubMed ID: 19690452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro human topical bioactive drug transdermal absorption: estradiol.
    Xing MM; Hui X; Zhong W; Pan N; Yaghmaie F; Maibach HI
    Cutan Ocul Toxicol; 2009; 28(4):171-5. PubMed ID: 19888886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The usual suspects-influence of physicochemical properties on lag time, skin deposition, and percutaneous penetration of nine model compounds.
    Bo Nielsen J; Ahm Sørensen J; Nielsen F
    J Toxicol Environ Health A; 2009; 72(5):315-23. PubMed ID: 19184747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion modeling of percutaneous absorption kinetics. 1. Effects of flow rate, receptor sampling rate, and viable epidermal resistance for a constant donor concentration.
    Anissimov YG; Roberts MS
    J Pharm Sci; 1999 Nov; 88(11):1201-9. PubMed ID: 10564070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico prediction of percutaneous absorption and disposition kinetics of chemicals.
    Chen L; Han L; Saib O; Lian G
    Pharm Res; 2015 May; 32(5):1779-93. PubMed ID: 25407547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated applications of a transdermal patch: analytical solution and optimal control of the delivery rate.
    Simon L
    Math Biosci; 2007 Oct; 209(2):593-607. PubMed ID: 17490691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstructed skin equivalents for assessing percutaneous drug absorption from pharmaceutical formulations.
    Zghoul N; Fuchs R; Lehr CM; Schaefer UF
    ALTEX; 2001; 18(2):103-6. PubMed ID: 11378682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of drug disposition kinetics in skin and plasma following topical administration.
    Guy RH; Hadgraft J
    J Pharm Sci; 1984 Jul; 73(7):883-7. PubMed ID: 6470948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Penetration kinetics of xanthotoxin across human skin and stratum corneum].
    Wang LY; Jöelle M; Huang FF; Yang DP
    Yao Xue Xue Bao; 2006 Sep; 41(9):878-81. PubMed ID: 17111837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure.
    Dancik Y; Miller MA; Jaworska J; Kasting GB
    Adv Drug Deliv Rev; 2013 Feb; 65(2):221-36. PubMed ID: 22285584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.